Wednesday, May 29, 2019

Epigenetic study provides new approaches to combination therapies for aggressive cancers

A recent study reveals how the interaction of the epigenetic protein BRD4 with the metabolic enzyme MTHFD1 controls gene expression and cell proliferation. The results of the study have now been published in the renowned journal Nature Genetics. They suggest novel approaches for the development of combination therapies for aggressive cancers.

from Top Health News -- ScienceDaily http://bit.ly/2YOyvfA

No comments:

Post a Comment

Hidden gut defect that may explain why IBD keeps coming back

Researchers have uncovered a hidden molecular warning sign of inflammatory bowel disease (IBD) that can linger even when patients feel well ...